Q-omics provides the consensus-scored DUXB profile across patient tissues and cancer cell-line models. Additionally, DUXB RNA expression shows 11,736 significant protein co-abundance associations, with the highest sampling consensus in LUAD.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for DUXB — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with DUXB in patient tissues and cancer cell lines. In patient samples, DUXB shows the broadest associations at the RNA and protein expression levels, with LUAD recurring as the lineage with the largest associated feature set. In cancer cell lines, DUXB RNA and mutation anchors are most strongly linked to RNA-expression features, especially in SKIN.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Protein (mass-spec)	11,736	LUAD (3924)	view →
Function (mass-spec)	909	HNSC (218)	view →

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼shRNA
shRNA	1,738	SKIN (286)	view →
CRISPR	1,737	SKIN (148)	view →